Detalles de la búsqueda
1.
ARID1A deficiency promotes progression and potentiates therapeutic antitumour immunity in hepatitis B virus-related hepatocellular carcinoma.
BMC Gastroenterol
; 24(1): 11, 2024 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38166741
2.
Intracranial efficacy of alectinib in ALK-positive NSCLC patients with CNS metastases-a multicenter retrospective study.
BMC Med
; 20(1): 12, 2022 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35039026
3.
[The Methylation of p16 Gene Promoter in Carcinogenesis and Development of Breast Cancer].
Sichuan Da Xue Xue Bao Yi Xue Ban
; 46(3): 409-12, 2015 May.
Artículo
en Zh
| MEDLINE | ID: mdl-26121863
4.
CHST7 Methylation Status Related to the Proliferation and Differentiation of Pituitary Adenomas.
Cells
; 11(15)2022 08 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35954244
5.
Genomic Alterations Identification and Resistance Mechanisms Exploration of NSCLC With Central Nervous System Metastases Using Liquid Biopsy of Cerebrospinal Fluid: A Real-World Study.
Front Oncol
; 12: 889591, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35814426
6.
Clinical outcome, long-term survival and tolerability of sequential therapy of first-line crizotinib followed by alectinib in advanced ALK+NSCLC: A multicenter retrospective analysis in China.
Thorac Cancer
; 13(1): 107-116, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34851035
7.
The Feasibility of Using Biomarkers Derived from Circulating Tumor DNA Sequencing as Predictive Classifiers in Patients with Small-Cell Lung Cancer.
Cancer Res Treat
; 54(3): 753-766, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34645133
8.
Evaluation of Clinical Outcomes of Icotinib in Patients With Clinically Diagnosed Advanced Lung Cancer With EGFR-Sensitizing Variants Assessed by Circulating Tumor DNA Testing: A Phase 2 Nonrandomized Clinical Trial.
JAMA Oncol
; 8(9): 1328-1332, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35862035
9.
Alectinib as first-line treatment for advanced ALK-positive non-small cell lung cancer in the real-world setting: preliminary analysis in a Chinese cohort.
Transl Lung Cancer Res
; 11(12): 2495-2506, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36636411
10.
Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: Predictors for response and prognosis.
Thorac Cancer
; 12(20): 2749-2757, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34423906
11.
Icotinib as Adjuvant Treatment for Stage II-IIIA Lung Adenocarcinoma Patients with EGFR Mutation (ICWIP Study): Study Protocol for a Randomised Controlled Trial.
Cancer Manag Res
; 12: 4633-4643, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32606956
Resultados
1 -
11
de 11
1
Próxima >
>>